🔬 Science 19h ago

Blockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs

Scientific American
Expert analysis on the most important developments in science
View Channel →
Source ↗ 👁 0 💬 0
The experimental weight-loss drug is a triple agonist and the first of its kind to reach a phase 3 clinical trial

Comments (0)

Sign in to join the discussion

More Like This

One Giant Clam Contains a Month‑by‑Month Diary of the Great Barrier Reef’s Climate 200 Years Ago
Nautilus · 5h ago
Passportless mess
Aeon | a world of ideas · 7h ago
📰
IVF ‘add-ons’ offer hope to parents desperate for a baby. But are they backed by science?
Scientific American Content: Global · 7h ago
📰
Why AI-powered romance scams are harder than ever to spot
Scientific American Content: Global · 7h ago
Woman's 5-year struggle with balance and walking was caused by a 'one-in-a-million' disorder
Latest from Live Science · 7h ago
Now is the best time to see Saturn all year — yes, even with the naked eye
Latest from Live Science · 7h ago